ERS clinical practice guidelines on treatment of sarcoidosisRobert P. Baughman, Daniel R. Ouellette, Paola Rottoli et al.|European Respiratory Journal|2021Cited by 579
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trialAthol U. Wells, Daniel F. Dilling, Kevin R. Flaherty et al.|The Lancet Respiratory Medicine|2020Cited by 558
Phenotypes of organ involvement in sarcoidosisJonas C. Schupp, Yvonne Kendrick, Sandra Freitag‐Wolf et al.|European Respiratory Journal|2018Cited by 245